Esperanza Arias - Publications

Affiliations: 
Pharmacology Universidad Autónoma de Madrid, Madrid, Comunidad de Madrid, Spain 
Area:
neuroprotection

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, ... ... Arias E, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382. PMID 33634751 DOI: 10.1080/15548627.2020.1797280  0.437
2006 Arias E, Gallego-Sandin S, del Barrio L, Villarroya M, Garcia AG, López MG. P4-295: Neuroprotective effects of acetylcholinesterase inhibitors Alzheimer's & Dementia. 2: S603-S604. DOI: 10.1016/J.Jalz.2006.05.2034  0.498
2005 Gallego-Sandín S, Novalbos J, Rosado A, Cano-Abad MF, Arias E, Abad-Santos F, García AG. Albumin prevents mitochondrial depolarization and apoptosis elicited by endoplasmic reticulum calcium depletion of neuroblastoma cells. European Journal of Pharmacology. 520: 1-11. PMID 16153637 DOI: 10.1016/J.Ejphar.2005.06.044  0.313
2005 Arias E, Gallego-Sandín S, Villarroya M, García AG, López MG. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics. 315: 1346-53. PMID 16144975 DOI: 10.1124/Jpet.105.090365  0.347
2004 Orozco C, de Los Rios C, Arias E, León R, García AG, Marco JL, Villarroya M, López MG. ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with "calcium promotor" and neuroprotective properties. The Journal of Pharmacology and Experimental Therapeutics. 310: 987-94. PMID 15111641 DOI: 10.1124/Jpet.104.068189  0.319
2004 Arias E, Alés E, Gabilan NH, Cano-Abad MF, Villarroya M, García AG, López MG. Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacology. 46: 103-14. PMID 14654102 DOI: 10.1016/S0028-3908(03)00317-4  0.336
Show low-probability matches.